JSM 2013 Home
Online Program Home
My Program

Abstract Details

Activity Number: 100
Type: Invited
Date/Time: Monday, August 5, 2013 : 8:30 AM to 10:20 AM
Sponsor: Section for Statistical Programmers and Analysts
Abstract - #307418
Title: Open Source Software in the Biopharma Industry: Challenges and Opportunities
Author(s): Jose Carlos Pinheiro*+
Companies: Janssen R&D
Keywords: R packages ; drug development ; software validation

Utilization of open source software, such as R and OpenBUGS, in clinical drug development conducted by the biopharmaceutical industry is, by and large, limited to simulations for trial/program design and exploratory analyses not included in regulatory submissions. A number of factors account for that, but chief among them is the (incorrect) perception that open source software cannot be validated and, therefore, is not accepted by regulatory agencies for analyses included in submission packages. Because research in statistical methodology increasingly makes its way into software via the open source route, this perception creates further hurdles for the utilization of novel statistical methods in an industry badly in need of innovative designs and analysis methods. This talk will discuss the challenges, perceived and real, to the broader utilization of open source software in clinical drug development and opportunities for addressing those challenges.

Authors who are presenting talks have a * after their name.

Back to the full JSM 2013 program

2013 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

ASA Meetings Department  •  732 North Washington Street, Alexandria, VA 22314  •  (703) 684-1221  •  meetings@amstat.org
Copyright © American Statistical Association.